Session 5
Lp(a): New Science, New Treatments – Will Patients Benefit?
Session five began with the lived experience of Gail Titus – a woman living with high Lp(a) but because of early diagnosis, she has avoided major cardiac events.
Presenters included Dr. Harpreet Bhatia, Dr. Michelle O’Donaghue, and Dr. Seth Baum highlighting data on the link between Lp(a) and Recurrent ASCVD events from the Family Heart DatabaseTM.
“Now we have to redefine normalcy and when these [Lp(a)] drugs finally get out and when we have access to them, we can’t be beholden to that one number… We have to push and fight hard to be able to access these drugs for our patients.”
– Dr. Seth Baum
“My health journey was forever changed by the sense of community and knowledge that I have gained through my affiliation with the Family Heart Foundation. Feeling empowered, I found myself educating my PCP, my hematology test, and other clinicians about Lp(a), and my LDL-C is finally in the safe zone”
– Gail Titus
